Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 70Neoplasms 7Neoplasm Metastasis 5Advanced Breast Cancer 5Carcinoma, Intraductal, Noninfiltrating 3Breast Carcinoma In Situ 3Neoplasms by Site 2Breast Neoplasms, Male 2Breast Diseases 2Skin Diseases 1Recurrence 1Quality of Life 1Low Grade Serous Ovarian Cancer 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Camurati-Engelmann Syndrome 1Breast Neoplasm Female 1Breast Cancer Metastatic 1Breast Cancer Female 1Bone Density 1Anatomic Stage II Breast Cancer AJCC v8 1Advanced Metastatic Breast Cancer 1

Interventions

exemestane 4Tamoxifen 3Paclitaxel 3Letrozole 3Goserelin 3Cyclophosphamide 3pegfilgrastim 2Radiotherapy 2Pyridoxine 2Leuprolide 2Fluorouracil 2Epirubicin 2Capecitabine 2Bevacizumab 2Anastrozole 2trastuzumab biosimilar HLX02 1ribociclib 1elacestrant 1Zoledronic Acid 1Trastuzumab 1Taxes 1Radiosurgery 1Prochlorperazine 1Palonosetron 1PF-05280014 1Ontruzant 1Ogivri 1Neoadjuvant Therapy 1Mometasone Furoate 1Methotrexate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Breast Neoplasms, Male × Anastrozole × Clear all
NCT06492616 2026-05-27

ELEGANT

Stemline Therapeutics, Inc.

Phase 3 Recruiting
4,220 enrolled
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT01674140 2026-02-10

e3

SWOG Cancer Research Network

Phase 3 Active not recruiting
1,939 enrolled 15 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡